Evidence map›Paper›PMID 30185536›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

DNA Methylation of

Yichen Guo, Ruyang Zhang, Sipeng Shen, Yongyue Wei, Sebastian Moran Salama, Thomas Fleischer, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Li Su and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Association of Methylation Level in thePharmacogenomics and personalized medicine · 2023
    Article
  5. Article
  6. Frontiers in oncology · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Yichen GuoDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Ruyang ZhangDepartment of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Sipeng ShenDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Yongyue WeiDepartment of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Sebastian Moran SalamaBellvitge Biomedical Research Institute and University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
Thomas FleischerDepartment of Genetics, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Maria Moksnes BjaanæsDepartment of Genetics, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Anna KarlssonDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Maria PlanckDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Li SuDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Zhaozhong ZhuDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-5662-1541
Johan StaafDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.ORCID 0000-0001-5254-5115
Åslaug HellandDepartment of Genetics, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.ORCID 0000-0002-5520-0275
Manel EstellerBellvitge Biomedical Research Institute and University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
David C ChristianiDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. dchris@hsph.harvard.edu.ORCID 0000-0002-0301-0242
Harvard University · USLund University · SEInstitució Catalana de Recerca i Estudis Avançats · ESNanjing Medical University · CNNorwegian Cancer Society · NOUniversity of Oslo · NO

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI JAIME ELIZABETH HART · 1985 to 2026
$44.6M
The HSPH Education and Research Center of Occupational Safety and HealthT42OH008416 · OH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2005 to 2025
$30.5M
The Boston Lung Cancer Survival CohortU01CA209414 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI David C Christiani · 2017 to 2026
$12.2M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI YEAP, BEOW Y · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
NCI NIH HHS P20 CA090578NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA092824NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA209414NIEHS NIH HHS P30 ES000002NIOSH CDC HHS T42 OH008416
6 · The paper itself

Abstract

backgroundPrevious studies support a tumor-suppressor role for

methodsThis study included 1,230 patients with early-stage NSCLC. DNA was extracted from lung tumor tissues and DNA methylation was measured using Illumina Infinium HumanMethylation450 BeadChips. The association between DNA methylation and OS was first tested using Cox regression on a discovery cohort and then validated in an independent cohort. Next, the association between DNA methylation and gene expression was investigated in two independent cohorts. Finally, the association between gene expression and OS was investigated in three independent groups of patients.

resultsThree novel DNA methylation sites in

conclusionsUsing clinical data from a large population, we illustrated the association between DNA methylation of IMPACT: We provide evidence of plausibility for building biomarkers on DNA methylation of

Indexed as

Biomarkers, TumorCarcinoma, Non-Small-Cell LungDNA MethylationFemaleHumansLung NeoplasmsMaleNeoplasm StagingSurvival AnalysisTranscriptomeBiomarkers, Tumor

Identifiers

PMID30185536
PMCPMC6279565
OpenAlexW2890370810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.